Rafael Holdings, Inc. RFL Noncurrent Prepaid Clinical Costs
Noncurrent Prepaid Clinical Costs at other companies
Other financials
Where this comes from
Reported directly by Rafael Holdings, Inc. in its filing.
Tagged under the XBRL concept rfl:NoncurrentPrepaidClinicalCosts.
The official record: Rafael Holdings, Inc.’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rafael Holdings, Inc.'s noncurrent prepaid clinical costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rafael Holdings, Inc.'s noncurrent prepaid clinical costs?
- Rafael Holdings, Inc. (RFL) reported noncurrent prepaid clinical costs of $244K in Q1 2026.
- What does noncurrent prepaid clinical costs mean?
- This represents long-term prepayments for clinical research and development services that are expected to be realized beyond the next twelve months. It reflects the company's multi-year investment strategy in its pharmaceutical pipeline. High balances indicate significant long-term commitments to future clinical trial milestones.